84 related articles for article (PubMed ID: 19891911)
1. Systemic drug-related intertriginous and flexural exanthema (SDRIFE).
Elmariah SB; Cheung W; Wang N; Kamino H; Pomeranz MK
Dermatol Online J; 2009 Aug; 15(8):3. PubMed ID: 19891911
[TBL] [Abstract][Full Text] [Related]
2. Lenalidomide-induced symmetrical drug-related intertriginous and flexural exanthema.
Patel RT; Quan EY; Eikenberg JD; Grider DJ; Phillips MA
Dermatol Online J; 2023 Aug; 29(4):. PubMed ID: 37921816
[TBL] [Abstract][Full Text] [Related]
3. Characterization of T-Helper Immune Phenotype in Symmetrical Drug-Related Intertriginous and Flexural Exanthema (SDRIFE) Endorses a Delayed-Type Hypersensitivity Reaction.
Chaudet KM; Russell-Goldman E; Horn TD; Schuler AM; Chan MP; Nazarian RM
Am J Dermatopathol; 2024 Feb; 46(2):71-78. PubMed ID: 38133537
[TBL] [Abstract][Full Text] [Related]
4. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients.
Kirven RM; Fisher K; Kaffenberger BH; Chung CG; Korman AM
Arch Dermatol Res; 2024 May; 316(6):279. PubMed ID: 38796524
[TBL] [Abstract][Full Text] [Related]
5. Rare case of itraconazole induced SDRIFE (symmetrical drug-related intertriginous and flexural exanthema).
Koschitzki K; Karrer S; Berneburg M; Niebel D; Drexler K
J Dtsch Dermatol Ges; 2024 Jun; 22(6):833-836. PubMed ID: 38567643
[No Abstract] [Full Text] [Related]
6. Docetaxel-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) confirmed by skin testing.
Hampel A; Kinaciyan T
Contact Dermatitis; 2024 May; 90(5):525-527. PubMed ID: 38263696
[No Abstract] [Full Text] [Related]
7. Histopathological Spectrum and Immunophenotypic Characterization of Symmetrical Drug-Related Intertriginous and Flexural Exanthema.
Muresan AM; Metze D; Böer-Auer A; Braun SA
Am J Dermatopathol; 2021 Feb; 43(2):103-111. PubMed ID: 32618703
[TBL] [Abstract][Full Text] [Related]
8. Zoledronic acid-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE).
Kandala H; Gonzalez-Mosquera LF; Barua P; Podrumar A
BMJ Case Rep; 2021 Sep; 14(9):. PubMed ID: 34518192
[No Abstract] [Full Text] [Related]
9. Symmetrical drug-related intertriginous and flexural exanthema (Baboon syndrome) associated with infliximab.
Bulur I; Keseroglu HO; Saracoglu ZN; Gönül M
J Dermatol Case Rep; 2015 Mar; 9(1):12-4. PubMed ID: 25932057
[TBL] [Abstract][Full Text] [Related]
10. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) after administration of corticosteroids: Case series and review of literature.
Steininger J; Bauer A; Hasler H; Beissert S; Abraham S
Contact Dermatitis; 2024 May; ():. PubMed ID: 38769741
[TBL] [Abstract][Full Text] [Related]
11. Unveiling the hidden culprit: A case report of recurrent SDRIFE caused by a systemic corticosteroid masquerading as antibiotic allergies.
Beaulieu V; Matei I; Bel Hareth K; Ingen-Housz-Oro S; Assier H
Contact Dermatitis; 2024 Jul; 91(1):88-90. PubMed ID: 38572964
[No Abstract] [Full Text] [Related]
12. Symmetric Drug-Related Intertriginous and Flexural Exanthema.
Mansilla Polo M; Martín-Torregrosa D
N Engl J Med; 2024 Feb; 390(7):e17. PubMed ID: 38354144
[No Abstract] [Full Text] [Related]
13. Symmetric drug-related intertriginous and flexural exanthema due to super-bioavailable itraconazole.
Dhabal A; Das NK; Sil A
Indian J Pharmacol; 2023; 55(3):192-193. PubMed ID: 37555417
[No Abstract] [Full Text] [Related]
14. Everolimus-induced Symmetrical Drug-related Intertriginous and Flexural Exanthema.
Kim EY; Awh KC; Larocca CA
Acta Derm Venereol; 2023 Dec; 103():adv12197. PubMed ID: 38112207
[No Abstract] [Full Text] [Related]
15. Skin microbial dysbiosis is a characteristic of systemic drug-related intertriginous and flexural exanthema-like lesions induced by EGFR inhibitor.
Liu W; Peng L; Chen L; Wan J; Lou S; Yang T; Shen Z
Heliyon; 2023 Nov; 9(11):e21690. PubMed ID: 38028014
[TBL] [Abstract][Full Text] [Related]
16. Symmetrical drug-related intertriginous and flexural exanthema: a rare and unusual drug eruption.
Lyons D; Barry R; Ni Raghallaigh S
BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38199652
[No Abstract] [Full Text] [Related]
17. Symmetrical cutaneous rash in two women.
Orioni G; Velez-Pelaez MC; Starace MVR; Tengattini V; Raschi E; La Placa M
Clin Case Rep; 2024 May; 12(5):e8877. PubMed ID: 38689690
[TBL] [Abstract][Full Text] [Related]
18. Two novel cases of delayed drug rash after immune checkpoint inhibitors and platin combination treatment.
Greimann E; Din R; McMorris M; Benjamin M; Kovalszki A
Ann Allergy Asthma Immunol; 2024 Mar; 132(3):397-399. PubMed ID: 38052375
[No Abstract] [Full Text] [Related]
19. Symmetrical Drug-Related Intertriginous and Flexural Exanthema Skin Reaction After Acetazolamide Use.
Cayenne SA; Anozie CC; Nanduri RS; Burgelin B; Alryalat SA; Al Deyabat O; Lee AG
J Neuroophthalmol; 2024 Apr; ():. PubMed ID: 38578696
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]